News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases 27/07/2021 Vall d’Hebron, UAB and UPC design an app to help assess the severity of symptoms in chronic fatigue syndrome 30/06/2021 Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat 16/06/2021 A work led by Vall d'Hebron demonstrates the relationship between immune-mediated inflammatory diseases and changes in diet 06/06/2021 Great participation of professionals from Vall d'Hebron in the 2nd National Congress of COVID-19 12/04/2021 Pagination « First First page ‹ Previous Previous page 1 2